Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Smallpox Vaccine (Lister Strain) Take and Safety in Healthy Adults
NCT00258947Phase 2Completed
- Sponsor
- Sanofi
- Start
- Sep 2005
- Primary completion
- Dec 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of smallpox vaccine (Lister strain) in smallpox, sponsored by Sanofi. Started Sep 2005; status: completed.
02
Drugs
smallpox vaccine (Lister strain)
03
Conditions
smallpox
Beyond the preview
Go deeper on NCT00258947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00258947.